RESUMEN
We describe a 40-year-old female who presented with progressive breathlessness and hypercapnic respiratory failure during pregnancy secondary to undiagnosed muscle-specific kinase myasthenia gravis. Her presentation was progressive and protracted, having over five contacts with healthcare professionals over nine months, many of these predating her pregnancy. Her atypical presentation for myasthenia with minimal limb weakness led to consideration of other causes of hypercapnic respiratory failure. Once diagnosed, she was treated with intravenous immunoglobulin and non-invasive ventilation. She gave birth to a pre-term infant by planned caesarean section. Her insidious presentation and the progressive nature of her breathlessness were unusual and our report highlights the predominant involvement of respiratory muscles in muscle-specific kinase myasthenia. Her pregnancy may have further delayed her diagnosis due the attribution of some symptoms to normal pregnancy. Early recognition and treatment of myasthenia gravis are important to prevent life-threatening complications.
RESUMEN
Myelin oligodendrocyte-antibody-associated disease (MOGAD) often presents with severe optic neuritis (ON) but tends to recover better than in aquaporin-4 antibody neuromyelitis optica spectrum disorder (AQP4-NMOSD). We measured OCT and VEP in MOGAD and AQP4-NMOSD eyes with good visual function, with or without previous ON episodes. Surprisingly, OCT and/or VEPs were abnormal in 84% MOGAD-ON versus 38% AQP4-NMOSD-ON eyes (p = 0.009) with good vision, compared with 18% and 17% respectively of eyes with no previous ON. A sub-group with macular OCT performed as part of a research study confirmed both retinal and macular defects in visually-recovered MOGAD eyes. These findings have implications for investigation and management of MOGAD patients.
Asunto(s)
Fiebre/terapia , Inmunoterapia/métodos , Mielitis Transversa/terapia , Adulto , Fiebre/líquido cefalorraquídeo , Fiebre/complicaciones , Fiebre/diagnóstico por imagen , Humanos , Imagen por Resonancia Magnética , Masculino , Mielitis Transversa/líquido cefalorraquídeo , Mielitis Transversa/complicaciones , Mielitis Transversa/diagnóstico por imagen , Bandas Oligoclonales/líquido cefalorraquídeoRESUMEN
BACKGROUND AND PURPOSE: Myasthenia gravis (MG) is an autoimmune disorder characterized by fatigable muscle weakness due to antibody-mediated impairment of neuromuscular transmission. The aim of this study was to investigate the incidence and prevalence of MG in Latvia, and to characterize this population by well-established clinical parameters such as age at onset, presence of associated antibodies and thymus pathology. METHODS: All prevalent cases on 1 January 2015 and cases of patients newly presenting with MG symptoms from 1 January 2010 to 31 December 2014 were selected from the database of the Neuromuscular Disease Clinic of Pauls Stradins Clinical University Hospital and Children's Clinical University Hospital. Crude rates were calculated based on population data. These were directly age-standardized to the European and World Health Organization world standard populations. The analysis of clinical characteristics was carried out in a cohort of patients who had undergone a complete set of electrophysiological, serological and radiological investigations (n = 153; 68%). RESULTS: During the study period 99 incident and 226 prevalent cases were identified. The total crude MG incidence was 9.7 per million person-years. The prevalence of MG on 1 January 2015 was 113.8 per million. 54.2% of patients tested positive for acetylcholine receptor antibodies, 7.8% for muscle specific kinase antibodies and 1.3% for lipoprotein related protein 4 antibodies. CONCLUSIONS: This is the first study of MG in Latvia and the second population-based study of MG in Eastern Europe. Our epidemiological results are similar to those in some other European and Northern American countries, and show high prevalence and increasing incidence of late-onset MG.
Asunto(s)
Miastenia Gravis/epidemiología , Adolescente , Adulto , Anciano , Anciano de 80 o más Años , Niño , Preescolar , Estudios Epidemiológicos , Femenino , Humanos , Incidencia , Lactante , Letonia/epidemiología , Masculino , Persona de Mediana Edad , Prevalencia , Adulto JovenRESUMEN
Severe, recurrent or bilateral optic neuritis (ON) often falls within the neuromyelitis optica spectrum disorders (NMOSD), but the diagnosis can be particularly challenging and has important treatment implications. We report the features, course and outcomes of patients presenting with atypical ON when isolated at onset. We retrospectively analyzed 69 sequential patients referred to a single UK NMO center with isolated ON at onset. Aquaporin-4 antibody (AQP4-Ab) assessment was performed in all patients and IgG1 myelin-oligodenrocyte glycoprotein (MOG-Ab) in AQP4-Ab(neg) patients. 37 AQP4-Ab positive (AQP4-Ab(pos)) and 32 AQP4-Ab negative (AQP4-Ab(neg)) patients (8 with MOG-Ab) were identified. The AQP4-Ab(neg) group included heterogeneous diagnoses: multiple sclerosis (MS), NMO, relapsing isolated ON (RION), monophasic isolated ON and relapsing acute disseminated encephalomyelitis (ADEM)-like syndromes. Compared to AQP4-Ab(neg) patients, AQP4-Ab(pos) patients had a worse residual visual outcome from first attack (median VFSS 4 vs. 0, p = 0.010) and at last assessment (median VFSS 5 versus 2, p = 0.005). However, AQP4-Ab(neg) patients with RION also had poor visual outcome. Up to 35% of AQP4-Ab(neg) patients developed a LETM and two developed low positivity for AQP4-Ab over time. Eight AQP4-Ab(neg) patients (25%) were MOG-Ab positive, covering a range of phenotypes excluding MS; the first ON attack was often bilateral and most had relapsing disease with a poor final visual outcome [VFSS 4, range (0-6)]. In conlcusion, AQP4-Ab positivity is confirmed as a predictor of poor visual outcome but AQP4-Ab(neg) RION also had a poor visual outcome. Of those without AQP4-Ab, 25% had MOG-Ab and another 25% developed MS; thus, MOG-Ab is associated with AQP4-Ab(neg) non-MS ON.
Asunto(s)
Autoanticuerpos/sangre , Neuromielitis Óptica/diagnóstico , Neuromielitis Óptica/inmunología , Adolescente , Adulto , Acuaporina 4/inmunología , Autoantígenos/inmunología , Niño , Preescolar , Femenino , Humanos , Inmunoglobulina G/sangre , Masculino , Persona de Mediana Edad , Glicoproteína Mielina-Oligodendrócito/inmunología , Neuromielitis Óptica/sangre , Neuritis Óptica/sangre , Neuritis Óptica/diagnóstico , Neuritis Óptica/inmunología , Pronóstico , Estudios Retrospectivos , Adulto JovenRESUMEN
The comparative clinical and demographic features of neuromyelitis optica (NMO) are not well known. In this review we analyzed peer-reviewed publications for incidence and prevalence, clinical phenotypes, and demographic features of NMO. Population-based studies from Europe, South East and Southern Asia, the Caribbean, and Cuba suggest that the incidence and prevalence of NMO ranges from 0.05-0.4 and 0.52-4.4 per 100,000, respectively. Mean age at onset (32.6-45.7) and median time to first relapse (8-12 months) was similar. Most studies reported an excess of disease in women and a relapsing course, particularly in anti-aquaporin 4 antibody (anti AQP4-IgG)-positive patients. Ethnicity may have a bearing on disease phenotype and clinical outcome. Despite limitations inherent to the review process, themes noted in clinical and demographic features of NMO among different populations promote a more global understanding of NMO and strategies to address it.
Asunto(s)
Neuromielitis Óptica/epidemiología , Neuromielitis Óptica/patología , Adulto , Femenino , Humanos , Masculino , Persona de Mediana EdadRESUMEN
BACKGROUND: Few data are available for patients with a late onset (≥ 50 years) of neuromyelitis optica (LONMO) or neuromyelitis optica spectrum disease (LONMOSD), defined by an optic neuritis/longitudinally extensive transverse myelitis with aquaporin-4 antibodies (AQP4-Ab). OBJECTIVE: To characterize LONMO and LONMOSD, and to analyze their predictive factors of disability and death. METHODS: We identified 430 patients from four cohorts of NMO/NMOSD in France, Germany, Turkey and UK. We extracted the late onset patients and analyzed them for predictive factors of disability and death, using the Cox proportional model. RESULTS: We followed up on 63 patients with LONMO and 45 with LONMOSD during a mean of 4.6 years. This LONMO/LONMOSD cohort was mainly of Caucasian origin (93%), women (80%), seropositive for AQP4-Ab (85%) and from 50 to 82.5 years of age at onset. No progressive course was noted. At last follow-up, the median Expanded Disability Status Scale (EDSS) scores were 5.5 and 6 in the LONMO and LONMOSD groups, respectively. Outcome was mainly characterized by motor disability and relatively good visual function. At last follow-up, 14 patients had died, including seven (50%) due to acute myelitis and six (43%) because of opportunistic infections. The EDSS 4 score was independently predicted by an older age at onset, as a continuous variable after 50 years of age. Death was predicted by two independent factors: an older age at onset and a high annualized relapse rate. CONCLUSION: LONMO/LONMOSD is particularly severe, with a high rate of motor impairment and death.
Asunto(s)
Actividad Motora , Neuromielitis Óptica/diagnóstico , Edad de Inicio , Anciano , Anciano de 80 o más Años , Acuaporina 4/inmunología , Autoanticuerpos/sangre , Biomarcadores/sangre , Causas de Muerte , Distribución de Chi-Cuadrado , Evaluación de la Discapacidad , Progresión de la Enfermedad , Europa (Continente)/epidemiología , Femenino , Humanos , Estimación de Kaplan-Meier , Masculino , Persona de Mediana Edad , Análisis Multivariante , Neuromielitis Óptica/inmunología , Neuromielitis Óptica/mortalidad , Neuromielitis Óptica/fisiopatología , Valor Predictivo de las Pruebas , Pronóstico , Modelos de Riesgos Proporcionales , Estudios Retrospectivos , Factores de Riesgo , Índice de Severidad de la Enfermedad , Factores de TiempoRESUMEN
OBJECTIVE: To describe 16 patients with a coincidence of 2 rare diseases: aquaporin-4 antibody (AQP4-Ab)-mediated neuromyelitis optica spectrum disorder (AQP4-NMOSD) and acetylcholine receptor antibody (AChR-Ab)-mediated myasthenia gravis (AChR-MG). METHODS: The clinical details and antibody results of 16 patients with AChR-MG and AQP4-NMOSD were analyzed retrospectively. RESULTS: All had early-onset AChR-MG, the majority with mild generalized disease, and a high proportion achieved remission. Fifteen were female; 11 were Caucasian. In 14/16, the MG preceded NMOSD (median interval: 16 years) and 11 of these had had a thymectomy although 1 only after NMOSD onset. In 4/5 patients tested, AQP4-Abs were detectable between 4 and 16 years prior to disease onset, including 2 patients with detectable AQP4-Abs prior to thymectomy. AChR-Abs decreased and the AQP4-Ab levels increased over time in concordance with the relevant disease. AChR-Abs were detectable at NMOSD onset in the one sample available from 1 of the 2 patients with NMOSD before MG. CONCLUSIONS: Although both conditions are rare, the association of MG and NMOSD occurs much more frequently than by chance and the MG appears to follow a benign course. AChR-Abs or AQP4-Abs may be present years before onset of the relevant disease and the antibody titers against AQP4 and AChR tend to change in opposite directions. Although most cases had MG prior to NMOSD onset, and had undergone thymectomy, NMOSD can occur first and in patients who have not had their thymus removed.
Asunto(s)
Miastenia Gravis/complicaciones , Miastenia Gravis/terapia , Neuromielitis Óptica/complicaciones , Neuromielitis Óptica/terapia , Adolescente , Adulto , Edad de Inicio , Anticuerpos , Acuaporina 4/inmunología , Autoanticuerpos , Encéfalo/patología , Niño , Femenino , Humanos , Estudios Longitudinales , Imagen por Resonancia Magnética , Masculino , Persona de Mediana Edad , Miastenia Gravis/sangre , Miastenia Gravis/inmunología , Neuromielitis Óptica/sangre , Neuromielitis Óptica/inmunología , Receptores Colinérgicos/inmunología , Estudios Retrospectivos , Timectomía , Adulto JovenRESUMEN
OBJECTIVE: To investigate the influence of pregnancy on patients with neuromyelitis optica spectrum disorder (NMOSD). METHODS: A total of 190 women with NMOSD were enrolled from 7 referral hospitals in 4 countries. We reviewed medical records and used a structured questionnaire to investigate gravidity, parity, and the number of relapses during the 2 years before pregnancy, during each trimester of pregnancy, during the first and second trimesters after delivery, and for 6 months thereafter. The annualized relapse rate (ARR) was calculated for each period. RESULTS: Of the 190 women with NMOSD, 40 patients experienced 54 informative pregnancies, and all of them were seropositive for aquaporin-4 antibody. Fourteen patients developed the first symptoms of NMOSD either during the pregnancy (3 patients) or within a year after delivery or abortion (8 and 3 patients, respectively). Twenty-six patients experienced 40 pregnancies after the onset of NMOSD (26 deliveries and 14 abortions [1 spontaneous and 13 elective]). There was one preterm delivery with birth defects and no stillbirths. The ARR during pregnancy did not differ from that before pregnancy, but it increased significantly during the first and second trimesters after delivery (5.3 and 3.7 times, respectively). Moreover, 77% of the deliveries were associated with postpartum relapses. CONCLUSION: The significantly increased relapse rate and numerous cases of NMOSD onset after pregnancy suggest that delivery adversely affects the course of NMOSD. Prospective studies are needed to confirm our findings.
Asunto(s)
Neuromielitis Óptica/epidemiología , Complicaciones del Embarazo/epidemiología , Aborto Inducido/estadística & datos numéricos , Adulto , Femenino , Humanos , Japón/epidemiología , Neuromielitis Óptica/diagnóstico , Portugal/epidemiología , Embarazo , Nacimiento Prematuro/epidemiología , Recurrencia , República de Corea/epidemiología , Reino Unido/epidemiologíaRESUMEN
OBJECTIVES: Neuromyelitis optica (NMO) immunoglobulin G (IgG) (aquaporin-4 [AQP4] IgG) is highly specific for NMO and related disorders, and autoantibody detection has become an essential investigation in patients with demyelinating disease. However, although different techniques are now used, no multicenter comparisons have been performed. This study compares the sensitivity and specificity of different assays, including an in-house flow cytometric assay and 2 commercial assays (ELISA and transfected cell-based assay [CBA]). METHODS: Six assay methods (in-house or commercial) were performed in 2 international centers using coded serum from patients with NMO (35 patients), NMO spectrum disorders (25 patients), relapsing-remitting multiple sclerosis (39 patients), miscellaneous autoimmune diseases (25 patients), and healthy subjects (22 subjects). RESULTS: The highest sensitivities were yielded by assays detecting IgG binding to cells expressing recombinant AQP4 with quantitative flow cytometry (77; 46 of 60) or visual observation (CBA, 73%; 44 of 60). The fluorescence immunoprecipitation assay and tissue-based immunofluorescence assay were least sensitive (48%-53%). The CBA and ELISA commercial assays (100% specific) yielded sensitivities of 68% (41 of 60) and 60% (36 of 60), respectively, and sensitivity of 72% (43 of 60) when used in combination. CONCLUSIONS: The greater sensitivity and excellent specificity of second-generation recombinant antigen-based assays for detection of NMO-IgG in a clinical setting should enable earlier diagnosis of NMO spectrum disorders and prompt initiation of disease-appropriate therapies.
Asunto(s)
Acuaporina 4/análisis , Inmunoensayo/normas , Inmunoglobulina G/análisis , Neuromielitis Óptica/diagnóstico , Adulto , Acuaporina 4/inmunología , Humanos , Inmunoglobulina G/inmunología , Neuromielitis Óptica/inmunología , Sensibilidad y EspecificidadRESUMEN
Longitudinally extensive transverse myelitis refers to florid and widespread inflammation of the spinal cord causing T2 hyperintensity on spinal magnetic resonance imaging that is seen to extend over three or more vertebral segments. Whilst rare, longitudinally extensive transverse myelitis is clinically important as it can lead to catastrophic morbidity, and a group of these patients are at risk of further attacks. Early identification and establishment of the underlying aetiology is vital in order to initiate appropriate therapy and optimize outcomes. Whilst longitudinally extensive transverse myelitis is classically associated with neuromyelitis optica, there are many other causes. These include other inflammatory aetiologies, infection, malignancy and metabolic disturbance. Some of these are readily treatable. Laboratory and radiological investigations can help to differentiate these causes. Treatment of longitudinally extensive transverse myelitis hinges on distinguishing inflammatory and non-inflammatory aetiologies and identifying patients who are at high risk of a recurrent course.
Asunto(s)
Mielitis Transversa/diagnóstico , Médula Espinal/patología , Enfermedades Autoinmunes/diagnóstico , Diagnóstico Diferencial , Humanos , Imagen por Resonancia Magnética , Esclerosis Múltiple/diagnóstico , Mielitis Transversa/patología , Neuromielitis Óptica/diagnóstico , RecurrenciaRESUMEN
BACKGROUND: The syndrome of progressive encephalopathy with limb rigidity has been historically termed progressive encephalomyelitis with rigidity and myoclonus (PERM) or stiff-person syndrome plus. METHODS: The case is presented of a previously healthy 28-year-old man with a rapidly fatal form of PERM developing over 2 months. RESULTS: Serum antibodies to both NMDA receptors (NMDAR) and glycine receptors (GlyR) were detected postmortem, and examination of the brain confirmed an autoimmune encephalomyelitis, with particular involvement of hippocampal pyramidal and cerebellar Purkinje cells and relative sparing of the neocortex. No evidence for an underlying systemic neoplasm was found. CONCLUSION: This case displayed not only the clinical features of PERM, previously associated with GlyR antibodies, but also some of the features associated with NMDAR antibodies. This unusual combination of antibodies may be responsible for the particularly progressive course and sudden death.
Asunto(s)
Anticuerpos/sangre , Encefalomielitis/sangre , Rigidez Muscular/sangre , Mioclonía/sangre , Receptores de Glicina/inmunología , Receptores de N-Metil-D-Aspartato/inmunología , Adulto , Encéfalo/patología , Encefalomielitis/complicaciones , Encefalomielitis/patología , Humanos , Masculino , Rigidez Muscular/complicaciones , Rigidez Muscular/patología , Mioclonía/complicaciones , Mioclonía/patología , Médula Espinal/patologíaAsunto(s)
Encefalomielitis/etiología , Rigidez Muscular/etiología , Mioclonía/etiología , Timectomía , Timoma/cirugía , Neoplasias del Timo/cirugía , Progresión de la Enfermedad , Humanos , Masculino , Persona de Mediana Edad , Timoma/complicaciones , Neoplasias del Timo/complicaciones , Resultado del TratamientoRESUMEN
A ação residual dos inseticidas imidacloprido/Beta-ciflutrina, clotianidina e clorfenapir foi avaliada para larvas de terceiro ínstar e adultos do predador Cycloneda sanguinea (Linnaeus). Sementes de algodão da cultivar BRS IPÊ foram semeadas em vasos de PVC e as plantas foram mantidas em casa de vegetação. Ao atingirem 25 dias de idade, as plantas foram pulverizadas com os produtos nas menores dosagens recomendadas pelos fabricantes, utilizando-se pulverizador manual. As concentrações foram em g i.a.L-1 de água: imidacloprido/Beta-ciflutrina (100/12,5 SC -0,25/0,03), clotianidina (500 PM 0,33) e clorfenapir (240 SC 0,80). Água destilada foi utilizada como testemunha. Folhas previamente marcadas em cada planta, de cada tratamento, foram retiradas e levadas ao laboratório e colocadas em placas de Petri contendo solução de ágar bacteriológico. Ovos de Anagasta kuehniella (Zeller) foram colocados sobre as folhas de algodoeiro e, em seguida, liberou-se um espécime por placa. As liberações ocorreram após 1, 12, 23 e 35 dias da pulverização dos compostos. Cada placa de Petri foi imediatamente vedada com filme de plástico PVC. O delineamento foi inteiramente casualizado com quatro tratamentos e doze repetições sendo que, para os testes com larvas, cada parcela foi formada por três espécimes e, para aqueles com adultos, cada repetição correspondeu a um casal. As avaliações de mortalidade foram feitas após 12, 24 e 48 horas das liberações. Os produtos foram classificados de acordo com o proposto pela Organização Internacional para Controle Biológico (IOBC). Todos os produtos foram enquadrados na classe 4 = persistentes, visto que mesmo a partir do trigésimo dia após sua aplicação causaram mais de 30,0% de mortalidade dos predadores.
The residual action of the insecticides imidacloprid/Beta-cyfluthrin, clothianidin and chlorfenapyr was evaluated in regard to third-instar larvae and adults of the predator Cycloneda sanguinea (Linnaeus). Cotton seeds of the cultivar BRS IPÊ were sowed in PVC pots and the plants were maintained in the greenhouse. Upon reaching 25 days of age, the plants were sprayed with the lowest dosages of the products recommended by the manufacturers, using a manual sprayer. The insecticides evaluated in g a.i.L-1 of water were imidacloprid/Beta-cyfluthrin (Imidacloprido/Beta-ciflutrina 100/12.5 CS 0.25/0.03), clothianidin (Clotianidina 500 WP 0.33) and chlorfenapyr (Clorfenapir 240 CS0.80). Distilled water was used as a control. Previously marked leaves, from each treatment, were removed from the plants and taken to the laboratory where they were placed in Petri dishes containing bacteriologic agar solution. Eggs of Anagasta kuehniella (Zeller) were placed on cotton leaves following the release of a Trichogramma specimen per dish after 1, 12, 23 and 35 days from pesticides application. Each Petri dish was immediately closed with plastic PVC film. A completely randomized experimental design was used, with 4 treatments and 12 replicates, each one formed by 3 third-instar larvae or 1 couple of adults. The number of dead larvae and adults in each treatment was examined 12, 24 and 48 hours after exposure to the chemicals. The products were classified according to categories proposed by the International Organization for Biological Control (IOBC). All the compounds tested were evaluated as class 4 = persistent, causing mortality above 30% up to 31 days after application on cotton leaves.
Asunto(s)
Pirroles/administración & dosificación , Escarabajos , Gossypium/parasitología , Neonicotinoides/administración & dosificación , Control de Insectos/métodos , Plagas AgrícolasRESUMEN
Paraneoplastic autoimmune diseases associate occasionally with small cell lung cancers and gynecologic tumors. However, myasthenia gravis (MG) occurs in at least 30% of all patients with thymomas (usually present at MG diagnosis). These epithelial neoplasms almost always have numerous admixed maturing polyclonal T cells (thymocytes). This thymopoiesis-and export of mature CD4(+)T cells-particularly associates with MG, though there are rare/puzzling exceptions in apparently pure epithelial WHO type A thymomas. Other features potentially leading to inefficient self-tolerance induction include defective epithelial expression of the autoimmune regulator (AIRE) gene and/or of major histocompatibility complex class II molecules in thymomas, absence of myoid cells, failure to generate FOXP3(+) regulatory T cells, and genetic polymorphisms affecting T-cell signaling. However, the strong focus on MG/neuromuscular targets remains unexplained and suggests some biased autoantigen expression, T-cell selection, or autoimmunization within thymomas. There must be further clues in the intriguing serological and cellular parallels in some patients with late-onset MG but without thymomas-and in others with AIRE mutations-and in the contrasts with early-onset MG, as discussed here.
Asunto(s)
Miastenia Gravis/inmunología , Síndromes Paraneoplásicos del Sistema Nervioso/inmunología , Timoma/inmunología , Timo/fisiopatología , Autoanticuerpos/inmunología , Autoantígenos/inmunología , Autoantígenos/metabolismo , Células Epiteliales/patología , Genes MHC Clase II , Humanos , Inmunoglobulina G/inmunología , Linfopoyesis , Miastenia Gravis/genética , Miastenia Gravis/fisiopatología , Síndromes Paraneoplásicos del Sistema Nervioso/genética , Poliendocrinopatías Autoinmunes/inmunología , Linfocitos T/inmunología , Timoma/genética , Timoma/patología , Timoma/fisiopatología , Factores de Transcripción/genética , Proteína AIRERESUMEN
This study describes a young girl who presented with involuntary weight loss, spontaneous vomiting and behavioural change. Imaging confirmed hypothalamic and brainstem involvement. Routine investigations (including cerebrospinal fluid analysis and neuromyelitis optica IgG) were unhelpful. Biopsy of the hypothalamic lesion implicated an aggressive inflammatory aetiology. There was a response to conventional immunosuppression, while a further relapse responded to plasma exchange. She died 21 months after presentation. Postmortem examination was highly suggestive of neuromyelitis optica, which was subsequently confirmed following the identification of aquaporin 4 antibodies.
Asunto(s)
Enfermedades Hipotalámicas/diagnóstico , Hipotálamo/patología , Imagen por Resonancia Magnética , Neuromielitis Óptica/diagnóstico , Adolescente , Acuaporina 4/inmunología , Autoanticuerpos/análisis , Biopsia , Tronco Encefálico/patología , Diagnóstico Diferencial , Progresión de la Enfermedad , Resultado Fatal , Femenino , Humanos , Enfermedades Hipotalámicas/inmunología , Enfermedades Hipotalámicas/patología , Necrosis , Examen Neurológico , Neuromielitis Óptica/inmunología , Neuromielitis Óptica/patología , Nervio Óptico/patología , Médula Espinal/patología , Tercer Ventrículo/patologíaRESUMEN
We studied the longitudinal relation between disease severity and titers of antigen-specific IgG subclasses in sera of patients with myasthenia gravis and antibodies to Muscle Specific Kinase (MuSK MG). Six patients were included of whom 55 samples had been collected during 2.5-13.4 years. Anti-MuSK antibodies were determined by ELISA and with a cell-based immunofluorescence assay. Disease severity was scored on a semi continuous scale. Only antigen-specific IgG4, and not IgG1, titers were significantly associated with disease severity in a linear mixed effect model (p = 0.036). Levels of IgG4 antibodies were above IgG1 in all samples except in one patient who went into clinical remission while switching from IgG4 to IgG1. The results support an important role for IgG4 in the pathogenesis of MuSK MG, in contrast to MG with anti-acetylcholine receptor antibodies.